Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07528326Not ApplicableNot Yet Recruiting

The TRICURE US IDE Pivotal Study

Role: lead

NCT06581471Not ApplicableRecruiting

The TRICURE EU Pivotal Study

Role: lead

NCT06506942Not ApplicableRecruiting

The TRICURE EFS Study

Role: lead

NCT05126030Not ApplicableActive Not Recruiting

The TRICURE First in Human Trial

Role: lead

All 4 trials loaded